Cancer Medicine

Article	Citations
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	387
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer	225
Issue Information	148
Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis	116
Impact of Body Image Perception on Behavioral Outcomes in Chinese Adolescent and Young Adult Survivors of Sarcoma	113
Issue Information	109
Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation	96
Physical Activity Patterns According to Demographic, Social, and Clinical Correlates Among Breast Cancer Survivors	95
Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides	91
Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma	85
	81
Intake of polyphenols from cereal foods and colorectal cancer risk in the Melbourne Collaborative Cohort Study	81
Reasoning and causal inference regarding surgical options for patients with low‐grade gliomas using machine learning: A SEER‐based study	72
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	72
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	71
Cancer and the family: Variations by sex and race/ethnicity	71
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APCmin/+‐induced colorectal cancer	65
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	63
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy	58
Physical activity, polygenic risk score, and colorectal cancer risk	57
Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and H	57
Impact of COVID ‐19 on Time to Treat Breast Cancer and Racial Disparities Among Women in the Military Health System From FY2	56
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	55
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	54
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	54

Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	53
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy	50
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data	48
Family physicians' involvement in palliative cancer care	47
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	46
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy	45
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)	45
Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer	44
Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis	44
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	44
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database	44
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis	44
Predicting Caregiver Anxiety and Depression From Patient Distress in Brain Tumor Dyads: Actor‐Partner Interdependence Model	43
Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy	43
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements	42
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes	42
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race	42
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review	42
Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on out	41
	41
Health‐related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma	41
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real‐World Impact of Ca	41
SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer	40
Body mass index and incident cardiometabolic conditions in relation to obesity‐related cancer risk: A population‐based cohort study in Catalonia, Spain	40
Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model	40
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi	40
Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial	40
Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age–period–cohort modeling study	39
Evaluating implementation of a hospital‐based cancer registry to improve childhood cancer care in low‐ and middle‐income countries	39
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II	39
Evaluation of an artificial intelligence support system for breast cancer screening in Chinese people based on mammogram	37
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer	37
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics	37
Risk Factors for Financial Toxicity in Patients With Pancreatic Cancer	37
Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study	37
Physical frailty deteriorates after a 5‐day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study	37
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	37
Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC	36
Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method	36
Associations of the Colon Tissue Microbiome and Circulating Bile Acids With Colorectal Adenoma Among Average‐Risk Women	36
Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross‐Species Translational Pathway	36
SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells	36
Improved Chemosensitivity in Metastatic Castration‐Resistant Prostate Cancer: The Synergistic Effects of S‐Adenosylmethionine and Cabazitaxel	36
Correction to “Characterization of Cancer Survivors Clustered by Subjective and Objective Cognitive Function Scores”	36
Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials	35
Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity	35
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer	35
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle‐invasive bladder cancer: A multi‐center, single‐arm, phase 2 study	35
Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results	35
Real‐World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China: Patterns, Trends, and Associated Factors From a Retrospective Cohort Study	34

Cervical Adenocarcinoma: What's Special About the Long‐Term Reproductive and Oncological Outcomes of Fertility‐Sparing Radical Trachelectomy in It?	34
Evaluating the impact of COVID‐19 on cancer declarations in Quebec, Canada	34
Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China	33
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer	33
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population	32
Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study	32
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy	32
Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer	32
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Canc	32
Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer	32
The Association Between Psychological Distress, Emergency Room Visits, and All‐Cause Mortality Among Colorectal Cancer Survivors	31
A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma	31
Second Primary Cancer After Bladder Cancer: A Comprehensive Analysis of a National Cancer Registry	31
Issue Information	31
Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC ‐	31
Initial Feasibility and Acceptability of Cancer Pain 101: An Interdisciplinary, Single‐Session, Telehealth Intervention for Patients With Cancer‐Related Pain	31
Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?	31
The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of TP53 mutations	31
Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis	31
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population‐Based Cohort Study	31
Real‐World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort	30
Machine Learning‐Based Model for Predicting Recurrence‐Free Survival After Interventional Therapy in Malnourished Hepatocellular Carcinoma Patients	30
Examining the involvement of guardians of children with acute lymphoblastic leukemia in Tanzania as public contributors to inform the design and conduct of the GuardiansCan project: A mixed	30
Impact of Adolescent and Young Adult Cancer Expertise in Oncologists on AYA Outcomes in Hodgkin Lymphoma: A Population‐Based Study in Ontario, Canada	30
Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience	30
Impact of Postdiagnosis Health Behaviors and Behavior Changes on Prognosis in Colorectal Cancer Patients: Evidence From Real‐World Data	30
Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet‐ PHL ‐ C1 Proto	30
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	30
Establishing a robust radioligand therapy program: A practical approach for North American centers	29
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population	29
Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race	29
Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus	28
Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer	28
Narrative Review of Patient Cancer Tissue–Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical Application	28
Cuproptosis gene‐related, neural network‐based prognosis prediction and drug‐target prediction for KIRC	28
Multi‐Transcriptomic Analysis Reveals That EREG ‐Driven TME Crosstalk Defines Anti‐	28
Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment	28
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications	28
A Systematic Review on the Role of Postoperative Radiotherapy in Pelvic Ewing Sarcoma	28
Pain experience of lung cancer patients during home recovery after surgery: A qualitative descriptive study	27
The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis	27
When Timing Matters Most: Early Relapse Outweighs Baseline Risk in Myeloma	27
Clinicopathological features of adult T‐cell leukemia/lymphoma with T‐follicular helper phenotype	27
Enrichment of Cancer‐Associated Fibroblasts, Macrophages, and Up‐Regulated TNF ‐α Signaling in the Tumor Microenvironment of	27
Roles of long noncoding RNA in triple‐negative breast cancer	27
Knowledge and Perception of Cervical Cancer and Pap‐Smear Screening Among Antenatal Women in Ogun State, Nigeria	27
Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population	27
Factor Structures of the Hospital Anxiety and Depression Scale in Cancer: Implications of Comprehensive Confirmatory Analysis on the German Version of the HADS in an Oncological Sample	27
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	27
Issue Information	26
Cost‐Effectiveness of Computer‐Assisted Cytology in a Primary hrHPV‐Based Cervical Cancer Screening Programme	26
Multi‐Omic Analysis Reveals the Impact of Bortezomib in Hyperleukocytic Acute Myeloid Leukemia	26
Brothers and sisters of childhood acute leukemia survivors: Their long‐term quality of life and its determinants	26
A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analys	26
Clinical factor‐based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix	26
Fertility preservation in male adolescents with cancer (2011–2020): A retrospective study in China	26
Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis	26
HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma	26
Second‐line treatment options in advanced thymic carcinoma after failure of platinum‐based chemotherapy: A multicenter retrospective study	26
Global incidence, risk factors, and temporal trends of nasal cancer: A population‐based analysis	26
A New Approach to Ultra‐Low Anterior Resection—Intersphincteric Dissection With Total Hiatal Ligament Excision for Very Low Rectal Cancer Located in the Posterior Wall of the Rectum: A More Satisfacto	26
	26
Efficacy of gemcitabine in combination with nanoparticle albumin‐bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review	26
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis	26
Clear cell renal cell carcinoma molecular variations innon‐HispanicWhite and Hispanic patients	25
Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis	25
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak	25
Why is end‐of‐life inpatient cost high among cancer patients? A prospective cohort study	25
A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation	25
Gastric cancer‐associated long non‐coding RNA profiling and noninvasive biomarker screening based on a high‐risk population cohort	25
Incidence and prevalence of musculoskeletal health conditions in survivors of childhood and adolescent cancers: A report from the Swiss childhood cancer survivor study	25
Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity	25
Examining the role of pre‐visit anxiety on patient uncertainty and breast cancer patient–provider communication	25
Association Between Systemic Immunity‐Inflammation Index (SII) and Fatigue, Cancer, and Cancer‐Related Fatigue: Insights From NHANES (2005–2018)	24
Quality of life and patient‐reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy	24
Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Scre	24
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma	24
Recent Developments and Evolving Therapeutic Strategies in KMT2A‐Rearranged Acute Leukemia	24
Association of Neighborhood Social Vulnerability With Metastatic Cancer at Diagnosis	24
Pretreatment Fatigue in Breast Cancer Patients: Comparison With Healthy Controls and Associations With Biopsychosocial Variables	24

RETRACTED: LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expr	24
Immune Cell Profiling Reveals a Common Pattern in Premetastatic Niche Formation Across Various Cancer Types	24
The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency	24
Bilateral Neck Dissection Effectively Improves Prognosis of Patients With T3N0M0 Glottic Carcinoma	24
Extracellular Volume Fraction Combined With Pathological Features of α‐SMA and FAP for Predicting the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma After Surgery and Evaluating the Effic	24
A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncolo	24
Carcinoid tumors outside the abdomen	23
Exosomal miR‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression	23
Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial	23
Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma	23
HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma	23
Major depression disorder may causally associate with the increased breast cancer risk: Evidence from two‐sample mendelian randomization analyses	23
Non‐Invasive Tumor‐Naïve Minimal Residual Disease Detection of Liver Cancer by Incorporating Circulating Tumor DNA Features and Alpha‐Fetoprotein: A Prospective Study	23
	23
Investigation on the regulatory T cells signature and relevant Foxp3/STAT3 axis in esophageal cancer	23
Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer	23
Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence	23
	23
The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan	23
	22
Dynamic alteration and prognostic significance of tumor‐associated CD68+ and CD68+PD‐L1− macrophages in muscle‐invasive bladder cancer treated with neoadjuvant chemoth	22
miR‐34a promotes the immunosuppressive function of multiple myeloma‐associated macrophages by dampening the TLR‐9 signaling	22
Quality of integrated female oncofertility care is suboptimal: A patient‐reported measurement	22
Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma	22
Exploring the perspective of adolescent childhood cancer survivors on follow‐up care and their concerns regarding the transition process—A qualitative content analysis	22
Real‐life challenges using personalized prognostic scoring systems in acute myeloid leukemia	22
Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG‐RC20‐06	22
Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma	22
Comparative Outcomes Between Black and White Patients With Early‐Stage Diffuse Large B‐Cell Lymphoma	22
Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China	22
Long‐Term Observation of Orbital Development in Patients With Retinoblastoma Following Unilateral Enucleation	22
Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan‐cancer analysis	22
Potentially functional variants of ERRFI1 in hypoxia‐related genes predict survival of non‐small cell lung cancer patients	22
Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers	22
	21
Association Between Transfusion Status, Hemoglobin Levels, and Patient‐Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis	21
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development	21
Correction to Fat mass and obesity‐associated protein regulates tumorigenesis of arecoline‐promoted human oral carcinoma	21
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity	21
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II<	21
Adverse Effects of Low Serum HDL ‐C Levels on Prognosis and Tumor Immune Microenvironment in Patients With Newly Diagnosed Chronic Lymphocytic Leukem	21
Symptom Network Analysis and Unsupervised Clustering of Oncology Patients Identifies Drivers of Symptom Burden and Patient Subgroups With Distinct Symptom Patterns	21
Tracing the evolving dynamics and research hotspots in the kidney neoplasm and nephron sparing surgery field from the past to the new era	21
The role of ATP‐binding cassette subfamily G member 1 in tumor progression	21
Impact of Methotrexate and 7‐Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non‐Hodgkin Lymphoma	21
Immunotherapy Administration and Survival for Stage IV Melanoma Patients at Minority‐Serving Hospitals	21
Sex‐based immune microenvironmental feature heterogeneity in response to PD ‐1 blockade in combination with chemotherapy for patients with untreated	21
NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon‐α2b Treatment	21
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study	20
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer	20
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation	20
Examining inequities associated with incarceration among breast cancer patients	20
Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study	20
Pilot study of implementing the Shared Healthcare Actions & Reflections Electronic systems in Survivorship (SHARE‐S) program in coordination with clinical care	20
Immunohistochemistry and oxygen saturation endoscopic imaging reveal hypoxia in submucosal invasive esophageal squamous cell carcinoma	20
Intraductal papillary carcinoma of breast with invasion: A nomogram and survival from the analysis of the SEER database	20
Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer	20
Understanding the financial cost of cancer clinical trial participation	20
The Effect of Financial Toxicity on the Association Between Perceived Social Support and Negative Emotions in Post‐Surgical Lung Cancer Patients: A Cross‐Sectional Study From High‐Middle Income Region	20
Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001–17	20
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials	20
Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer	20
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy	20
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies	20
Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma	20
Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real‐world experiences over a 2‐year period	20
Survival and prognostic factors of early‐stage non‐small cell lung cancer in Central and Eastern Europe: A prospective cohort study	20
Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study	20
Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Mainte	20
High expression of caspase‐8 as a predictive factor of poor prognosis in patients with esophageal cancer	20
Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling	20
Do corticosteroids affect immunotherapy efficacy in malignancy? – A systematic review	20
β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma	20
From Gene to Enzyme: Multidimensional Decoding of the GGT Molecular Family and Its Clinical Tumor Diagnosis	19
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas	19
An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes	19
Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study	19
Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy	19
CD79BY196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma	19
Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision‐making?	19
Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway	19
TWEAK /Fn14 Drives Tumor Progression and Is Associated With Poor Survival of Colorectal Liver Metastases With Replacement Growth Patterns	19
MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients	19
Burden of Middle‐Aged and Elderly Patients With Non‐Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021	19
Primary care patient interest in joining a planned multi‐cancer early detection clinical trial	19
Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer	19
Vaspin accelerates the proliferation, invasion and metastasis of Triple‐Negative breast cancer through MiR‐33a‐5p/ABHD2	19
Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway	19
Ubiquitin‐Specific Protease 45 Inhibits Lung Adenocarcinoma Ferroptosis by Regulating Ubiquitination and Stability of Glutathione Peroxidase 4	19
Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 Pathway	19
Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma	19
Correction to: Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study	19
Differences in Tumor‐Infiltrating Lymphocyte Counts in the Peritumoral Area in Patients Undergoing Hepatic Resection After Lenvatinib and Atezolizumab Plus Bevacizumab Therapy for Hepatocellular Carci	18
The causal relationship between osteoarthritis and bladder cancer: A Mendelian randomization study	18
Central Nervous System Prophylaxis Approach in High‐Risk Diffuse Large B‐Cell Lymphoma Patients: A Retrospectively Collected, Single‐Center Cohort Analysis	18